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Background: Kawasaki disease (KD) is a generalized systemic vasculitis of unknown etiology involving medium and
small size blood vessels, particularly the coronary arteries. In these vessels a progressive stenosis may result from
active remodeling with an intimal proliferation and neoangiogenesis. The aim of our study was to assess, by using
high-resolution transthoracic 2D Echocardiography, if subjects with a previous diagnosis of Kawasaki disease after
several years show a coronary intimal thickening, suggestive of a persistent cardiovascular risk.
Methods: We assessed measurement of thickening, inner diameter and outer diameter of coronary arteries using
2D Echocardiography (Philips E 33 with multy-frequency S8-3 and S12-4 probes) and examining the proximal
portion of left main coronary artery just above the aortic valve with parasternal short axis view.
Results: We found a significant intimal thickening in patients with previous Kawasaki disease compared to healthy
controls. In particular, we noticed that also subjects not suffering from coronary impairment in acute phase have
higher values of thickening than healthy controls, and this wall thickening may confer a higher cardiovascular risk.
Conclusions: Therefore we concluded that the assessment of coronary artery thickening by high-resolution
transthoracic 2D Echocardiography may become an essential instrument to evaluate late cardiovascular risk in
subjects with a diagnosis of Kawasaki disease in childhood.
Keywords: Kawasaki disease, High resolution transthoracic echocardiography, Cardiovascular risk, Coronary
intimal thickeningBackground
Kawasaki disease (KD) is a systemic vasculitis affecting
infants and young children [1,2] which may potentially
involve heart [3], small and medium-size arteries, and
can lead to the formation of aneurysms, especially in the
coronary arteries [4,5].
During the acute phase of the disease, mortality peaks
from 15 to 45 days after the onset of fever, usually due
to cardiac sequelae such as arrhythmia and myocardial
infarction (MI) [5,6]. It has been noticed that sudden* Correspondence: valentina.giacchi@yahoo.it
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unless otherwise stated.death from myocardial infarction may also occur after
many years in individuals who had previously developed
coronary artery aneurysms (CAA) and stenosis, and it
seems today that several cases of fatal and nonfatal MIs
in young adults have been attributed to “missed” KD
diagnosis in childhood [5].
Regarding the pathogenesis of vascular damage, it is
well-known that in Kawasaki disease an arterial active
remodeling occurs due to intimal proliferation and
neoangiogenesis; the intima, rich in smooth muscle cells,
and fibrous layers, appears markedly thickened with
linearly-arranged microvessels [6].
It has lately been noticed that the high resolution
transthoracic echocardiography is able to detect intimalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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scending (LAD) coronary arteries in adults with subclin-
ical atherosclerosis [7,8]. We hypothesized that this
technique, applied to the study of proximal left main cor-
onary artery, could be useful in monitoring the follow-up
of KD after the acute phase.
The aim of the present study was to assess coronary
artery intimal thickening by using high resolution trans-
thoracic 2D Echocardiography in patients with a previ-
ous diagnosis of Kawasaki disease several years after the
acute event.Methods
We conducted an observational cross-sectional case–con-
trol double-blind study on 31 patients with a previous
diagnosis of KD who had been hospitalized in childhood
since January 1990 to December 2000 in our Pediatric
Department of the University of Catania, Italy.
Every patient if of age, or at least one parent or legal
guardian if underage, gave their written informed consent
before the patient’s inclusion in the study. The study was
conducted in accordance with the Helsinki Declaration,
and the study protocol was approved by the (local) Ethics
Committee of the Medical University of Catania.
Five patients were omitted from the study as they were
current smokers. In the same way we recruited 26 vol-
untary healthy subjects among students of school and
University to be used as controls.
The main features of the 26 patients at the moment of
diagnosis are reported in Table 1.
The diagnosis of Kawasaki disease was performed ac-
cording to the criteria of the American Heart Association
(AHA) Committee on Rheumatic fever, Endocarditis and
Kawasaki disease [9,10]: a typical form of Kawasaki disease
was detected in 14 patients (53.3%), an incomplete form
in 9 (34.6%) and an atypical form in 3 (11.5%).
Every patient was assigned to corresponding risk class:
20 (76.9%) to the first risk class, 3 (11.5%) to the second, 2
(7.7%) to the third and 1 (3.9%) to the fourth. All patients
belonging to third and fourth risk classes were affected by
typical form, whereas patients of first and second classes
presented typical, atypical or incomplete form.Table 1 Features of 26 patients at diagnosis
Gender Clinical form ECG Cardiac manifestat
M:18 (69.2%) T: 14 (53.8%) N: 12 (46.2%) NCI: 14 (54%)
F:8 (30.8%) I: 9 (34.6%) SST: 9 (34.6%) TAC: 3 (11.5%)
A: 3 (11.5%) PRBBB: 3 (11.5%) PAC: 3 (11.5%)
NSDVR: 2 (7.7%) PE: 3 (11.5%)
MR: 3 (11.5%)
Abbreviations: M male, F female, T Typical, I Incomplete, A Atypical, N normal, SST sl
non-specific disorders of ventricular repolarization, NCI no cardiac impairment, TAC
PE pericardial effusion, MR mitral regurgitation.According to the guidelines at the time of diagnosis,
20/26 (76.9%) had been on both acetylsalicylic acid and
intravenous immunoglobulin (IVIG) therapy, (400–500 mg/
Kg/day for 4–5 consecutive days or 1–2 g/Kg in a single
dose), 3/26 (11.5%) only on acetylsalicylic acid therapy, 2/26
(7.7%) only on IVIG therapy, whereas in a single case (3.9%)
the parents refused therapy.
At present, the age ranges from 4 to 27, with an average
of 13.3 ± 7.4 and a time from the beginning of the illness
ranging from 3 to 22 years.
We performed Electrocardiogram and 2D Echocardiog-
raphy in all patients.
The laboratory and cardiologic data were compared
with those of the 26 healthy subjects of the same age.
The same experienced echocardiographer, unaware of
whether he was dealing with a case or a control, assessed
measurement of thickening, inner diameter and outer
diameter of coronary arteries using 2D Echocardiography
(Philips E 33 with multy-frequency S8-3 and S12-4 probes,
using the setting scheduled by the echo machine) and
examining the proximal portion of left main coronary
artery just above the aortic valve with parasternal short
axis view. Echocardiographic recordings of four separate
cardiac cycles were captured by zoom image. Optimal gain
setting was adjusted for maximal delineating the outer
edge from the inner edge of the line representing the
vascular wall. The thicker walled vascular structure was
identified as multiple linear echoes which branched off
just above from the aortic valve and was measured edge to
edge at diastolic period.
Statistical analysis
We calculated means, standard deviation, standard error
(SE) and Median for all variables. We adjusted values of
coronary thickening for BSA (Body Surface Area) and per-
formed t-student and Mann–Whitney test to compare
these values between cases and controls.
P value < 0.05 was considered statistically significant.
Results
We have not found any significant difference in subjective
and laboratory parameters between patients and healthy
controls Table 2. Both cases and controls presentedions Risk class Therapy Age at diagnosis
I: 20 (76.9%) ASA + IVIG 20 (76.9%) < 6 ms: 2 (7.7%)
II: 3 (11.5%) ASA 3 (11.5%) 6 ms- 5 ys: 21 (80.8%)
III: 2 (7.7%) IVIG 2 (7.7%) > 5 ys:3 (11.5%)
IV: 1 (3.9%) No therapy 1 (3.9%)
ight sinus tachycardia, PRBBB partial right bundle branch block, NSDVR
transient anomalies of coronaries, PAC persistent anomalies of coronaries,
Table 3 Thickening and thickening adjusted for BSA in
cases and healthy controls
Parameter Cases Controls P Value
Thickening (mm) 3.5 ± 2.2 1.9 ± 0.6 < 0.01
Thickening adjusted for BSA (mm) 5.3 ± 4.4 2.7 ± 1.2 < 0.01
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blood pressure and nobody was alcohol drinker or had
any other risk factor for atherosclerotic disease.
The Electrocardiogram did not show any signs of ische-
mia in either cases and controls.
The 2D Echocardiographic assessment of systolic and
diastolic function showed normal values in both patients
and healthy controls.
We confirmed persistent anomalies of coronary arteries
already described at diagnosis in two of the patients (one
patient with a giant aneurism of left coronary artery and
another one with two aneurisms in the left and right cor-
onary arteries respectively), both with previous diagnosis
of typical KD, assigned to 3 and 4 risk class respectively.
Regarding intimal thickness, we detected significant
higher thickening values adjusted for BSA in cases than
healthy controls (5.3 mm± 4.4, Median 3.7, SE 0.8, versus
2.7 mm± 1.2, Median 2.6, SE 0.2, p <0.01) Table 3.
Assessing the main values of thickening adjusted for
BSA in the different risk classes, we found values equal to
4.5 mm± 3.7, Median 3.4, SE 0.8 in the risk class 1 and,
assembling patients belonging to risk classes 2-3-4, we de-
tected values equal to 7.9 mm± 5.8, Median 6.0, SE 2.4 in
the risk class 2-3-4 group. We noticed significant differ-
ence in thickening values between controls and patients
belonging to risk class 1 and in controls and patients
belonging to risk class 2-3-4 group (p < 0.05) but not
between patients belonging to risk class 1 and patients
belonging to risk class 2-3-4 group (p = ns) Table 4.Discussion
Our study might provide new data in the long-term
follow-up of Kawasaki disease since our patients showed a
significant thickening of coronary intimal wall not related
to the severity of the Kawasaki disease during the acuteTable 2 Subjective and laboratory parameters in cases
and healthy controls
Variables Cases Controls P value
Age (years) 13.3 ± 7,4 12.6 ± 7,4 ns
Male 69% 73% ns
Female 31% 27% ns
BMI 20.4 ± 3.9 20.6 ± 2.8 ns
BSA (m2) 1.33 ± 0.44 1.36 ± 0.40 ns
Total cholesterol (mg/dl) 177 ± 22 170 ± 36 ns
Triglycerides (mg/dl) 61 ± 29 65 ± 24 ns
Low density lipoprotein (mg/dl) 110 ± 19 110 ± 18 ns
C-reactive protein > 0,10 (mg/dl) 11.5% 7.7% ns
Platelets (x103)/mmc 309 ± 93 359 ± 114 ns
Systolic blood pressure (mmHg) 110 ± 14.4 108 ± 12 ns
Diastolic blood pressure (mmHg) 64 ± 9.8 63 ± 11 nsphase. Coronary intimal alteration could indirectly mean a
higher cardiovascular risk.
It has been noticed that in coronary atherosclerosis, a
diffuse disease process that rarely spares the proximal cor-
onary arteries, a severe intimal thickening may be assessed
as a site of localized stenosis. Accurate baseline measure-
ments of the luminal and external diameters and wall
thickness of proximal and mid LAD coronary artery have
proved to be obtainable by using the high resolution
transthoracic echocardiography techniques [11,12].
We successfully applied the same method to the prox-
imal left main coronary artery: by using high resolution
transthoracic probes we detected in morphology of prox-
imal left main coronary artery structural features not so
far different from atherosclerosis-induced positive remod-
eling, already showed in other coronary vascular territor-
ies of patients with confirmed significant luminal coronary
artery disease [13].
In fact studies prior to IVIG therapy showed that a
potential mechanism of coronary artery occlusion in long-
term KD could be represented by the progression of the
thickening of intimal layer and particularly, but not only,
in the aneurysm inlet or outlet which is often associated
to calcification [14,15]. This, with any combination of
thrombus formation [16] might lead to acute myocardial
infarction in young adults with sequelae of KD after
several years [17].
Afterwards, Takahashi et al. histologically examined
twenty-four arteries of six autopsy cases of patients older
than 15 years with coronary arterial lesions caused by ar-
teritis in childhood and detected in both patients without
aneurysms and those with manifest recanalized lumens
after thrombotic occlusion of the aneurysms “new intimal
thickening” in addition to the preexisting intimal thicken-
ing caused by arteritis in the acute phase of KD. TheyTable 4 Thickening and thickening adjusted for BSA in
controls, patients belonging to risk class 1 and patients





A (Controls) 1.9 ± 0.6 2.7 ± 1.2
B (Risk class 1) 3.0 ± 1.7 4.5 ± 3.7
C (Risk class 2-3-4) 5.3 ± 3.1 7.9 ± 5.8
Thickening: A versus B: p < 0.01; A versus C:p < 0.01; B versus C: NS;
Thickening adjusted for BSA: A versus B: p < 0.05; A versus C:p < 0.05;










Figure 2 Normal left coronary artery. Legend: External diameter; Internal diameter; Superior thickening; Inferior thickening.
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factor for atherosclerosis later in life [18].
Iemura et al. found various degrees of intimal thickening
but normal media on intravascular ultrasound imaging of
the sites of regressed aneurysms. These intravascular ultra-
sound findings were similar to those in arteriosclerosis [19].
Intimal thickening, detectable in proximal left main cor-
onary artery, occurs as a result of augmented vascular
smooth muscle cell proliferation, in addition to increased
vascular smooth muscle cell migration, extracellular
matrix synthesis and phenotypic change [20,21].
It has recently been proposed that the Wnt/β-catenin
pathway, involved in the regulation of embryogenesis and
development, but also in cell proliferation, differentiation,
polarity, migration, and invasion [22], plays a role in vas-
cular smooth muscle cell proliferation and thereby intimal
thickening [23-29].
Therefore, the risk for later KD complications suggests
the necessity of a long-term follow-up of KD patients
beyond childhood years.
We showed that the left main coronary artery wall
thickness of subjects with previous Kawasaki disease
were significantly larger (Figure 1) than those of healthy
subjects (Figure 2) such as indicating atherosclerotic dis-
ease. The inner diameters, instead, were normal in both
controls and cases, also in those with previous transient
aneurysms suggesting, as an explanation, the phenomenon
of positive remodeling.
Conclusion
Our study shows the high sensibility of high resolution
transthoracic 2D Echocardiography to the detection of
minimal alterations in coronary wall due to intimal thick-
ening in patients with previous Kawasaki disease, also if
studied several years after acute phase. In our experience,
all patients with a previous diagnosis of Kawasaki disease,
independently from the risk class, present a significant
thickening of coronary arteries if compared to healthy
controls. We state that this may result in premature
atherosclerotic cardiovascular disease and therefore the
measurement of coronary intimal thickening by high-
resolution transthoracic 2D Echocardiography should be
added to the follow-up protocol of Kawasaki disease be-
cause of its uninvasiveness and reproducibility.
Further investigation is obviously requested to confirm
our data. We suggest that this be studied in a larger,
multi-institutional study.
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